Announcements Trials

Browse Landscape

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Stomach Neoplasms 135 Pancreatic Neoplasms 36 Esophageal Neoplasms 19 Biliary Tract Neoplasms 19 Colorectal Neoplasms 17 Esophageal Squamous Cell Carcinoma 12 Neoplasm Metastasis 10 Cholangiocarcinoma 8 Carcinoma, Non-Small-Cell Lung 7 Gastrointestinal Neoplasms 6 Nasopharyngeal Carcinoma 5 Colonic Neoplasms 5 Adenocarcinoma 5 Recurrence 4 Neoplasms 4 Head and Neck Neoplasms 4 Advanced Pancreatic Cancer 4 Advanced Gastric Cancer 4 Rectal Neoplasms 3 Gastric Adenocarcinoma 3 Gallbladder Neoplasms 3 Advanced Solid Tumors 3 Stage IV Gastric Cancer With Metastasis 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 NSCLC 2 Locally Advanced Pancreatic Cancer 2 Locally Advanced Gastric Cancer 2 Gastric Cancer Peritoneal Metastases 2 Carcinoma, Transitional Cell 2 Carcinoma, Hepatocellular 2

Interventions

pembrolizumab 14 Injections 13 Paclitaxel 10 Nivolumab 10 Docetaxel 9 Cisplatin 9 Capecitabine 9 Bevacizumab 8 toripalimab 7 senaparib 7 Fluorodeoxyglucose F18 7 Cyclophosphamide 7 tislelizumab 6 atezolizumab 6 Irinotecan 6 Fluorouracil 6 Gemcitabine 5 fludarabine 4 apatinib 4 Oxaliplatin 4 Leucovorin 4 Ipilimumab 4 Carboplatin 4 spartalizumab 3 sintilimab 3 pertuzumab 3 olaparib 3 camrelizumab 3 Rifampin 3 Radiosurgery 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Tumor × S 1 (combination) × Clear all

NCT04260269 2024-12-12

CardioSwitch

Helsinki University Central Hospital

Enrolling by invitation

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡